OUP user menu

Zafirlukast (Accolate): A New Treatment for Capsular Contracture

S. Larry Schlesinger , Richard Ellenbogen , Michael N. Desvigne , Steven Svehlak , Robert Heck
DOI: http://dx.doi.org/10.1067/maj.2002.126753 329-336 First published online: 1 July 2002


Background Capsular contracture after breast augmentation or reconstructive breast surgery is a difficult problem. Previous studies have suggested that alteration of the inflammatory response could have a role in reducing the incidence of capsular contracture.

Objective We report a series of patients with Baker class III or IV capsular contracture who underwent treatment with zafirlukast.

Methods Patients received a regimen of zafirlukast 20 mg by mouth 2 times daily for 3 months.

Results In many cases, dramatic softening of the breast capsule was evident after 1 to 3 months of treatment.

Conclusions Zafirlukast appears to effectively soften early capsular contracture and may prevent the formation of capsular contracture in those patients at risk.

View Full Text

Log in through your institution